These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 34560064)
21. Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption. Binder N; Miller C; Yoshida M; Inoue K; Nakano S; Hu X; Ivashkiv LB; Schett G; Pernis A; Goldring SR; Ross FP; Zhao B J Immunol; 2017 May; 198(9):3436-3447. PubMed ID: 28314855 [TBL] [Abstract][Full Text] [Related]
22. Hypoxic dental pulp stem cells-released succinate promotes osteoclastogenesis and root resorption. Yang A; Wang J; Yang Z; Wang L; Li H; Lei L Int J Med Sci; 2024; 21(6):1155-1164. PubMed ID: 38774749 [No Abstract] [Full Text] [Related]
23. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis Yang J; Tang R; Yi J; Chen Y; Li X; Yu T; Fei J FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415 [TBL] [Abstract][Full Text] [Related]
24. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [TBL] [Abstract][Full Text] [Related]
25. Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells. Liu M; Liu S; Zhang Q; Fang Y; Yu Y; Zhu L; Liu Y; Gong W; Zhao L; Qin L; Zhang Q J Ethnopharmacol; 2021 Jul; 275():114129. PubMed ID: 33878416 [TBL] [Abstract][Full Text] [Related]
26. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Brandi ML; Hukkanen M; Umeda T; Moradi-Bidhendi N; Bianchi S; Gross SS; Polak JM; MacIntyre I Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2954-8. PubMed ID: 7535933 [TBL] [Abstract][Full Text] [Related]
28. Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha. Lee SK; Huang H; Lee SW; Kim KH; Kim KK; Kim HM; Lee ZH; Kim HH Exp Cell Res; 2004 Aug; 298(2):359-68. PubMed ID: 15265685 [TBL] [Abstract][Full Text] [Related]
29. Deguelin inhibits RANKL-induced osteoclastogenesis in vitro and prevents inflammation-mediated bone loss in vivo. Zhang T; Zhao K; Han W; Yang W; Lu X; Liu Q; Li X; Qian Y J Cell Physiol; 2019 Mar; 234(3):2719-2729. PubMed ID: 30078209 [TBL] [Abstract][Full Text] [Related]
30. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. van't Hof RJ; Ralston SH J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684 [TBL] [Abstract][Full Text] [Related]
31. Afamin stimulates osteoclastogenesis and bone resorption via Gi-coupled receptor and Ca2+/calmodulin-dependent protein kinase (CaMK) pathways. Kim BJ; Lee YS; Lee SY; Park SY; Dieplinger H; Yea K; Lee SH; Koh JM; Kim GS J Endocrinol Invest; 2013 Nov; 36(10):876-82. PubMed ID: 23698732 [TBL] [Abstract][Full Text] [Related]
32. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta. Lari R; Fleetwood AJ; Kitchener PD; Cook AD; Pavasovic D; Hertzog PJ; Hamilton JA Bone; 2007 Feb; 40(2):323-36. PubMed ID: 17055352 [TBL] [Abstract][Full Text] [Related]
33. Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism. Jia Y; Jiang J; Lu X; Zhang T; Zhao K; Han W; Yang W; Qian Y J Cell Physiol; 2019 May; 234(5):7498-7509. PubMed ID: 30471112 [TBL] [Abstract][Full Text] [Related]
34. The Adenosine A Knowles HJ Cells; 2019 Jun; 8(6):. PubMed ID: 31234425 [TBL] [Abstract][Full Text] [Related]
35. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss. Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498 [TBL] [Abstract][Full Text] [Related]
36. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast. Hong SE; Lee J; Seo DH; In Lee H; Ri Park D; Lee GR; Jo YJ; Kim N; Kwon M; Shon H; Kyoung Seo E; Kim HS; Young Lee S; Jeong W Free Radic Biol Med; 2017 Nov; 112():191-199. PubMed ID: 28774817 [TBL] [Abstract][Full Text] [Related]
37. Regulation of TRPV5 transcription and expression by E2/ERα signalling contributes to inhibition of osteoclastogenesis. Song T; Lin T; Ma J; Guo L; Zhang L; Zhou X; Ye T J Cell Mol Med; 2018 Oct; 22(10):4738-4750. PubMed ID: 30063124 [TBL] [Abstract][Full Text] [Related]
38. Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway. Liu G; Ma C; Wang P; Zhang P; Qu X; Liu S; Zhai Z; Yu D; Gao J; Liang J; Dai W; Zhou L; Xia M; Yang H Biochem Biophys Res Commun; 2017 Sep; 491(2):388-395. PubMed ID: 28733032 [TBL] [Abstract][Full Text] [Related]
39. A possible role for nitric oxide in osteoclastogenesis associated with cholesteatoma. Jung JY; Pashia ME; Nishimoto SY; Faddis BT; Chole RA Otol Neurotol; 2004 Sep; 25(5):661-8. PubMed ID: 15353992 [TBL] [Abstract][Full Text] [Related]
40. Melatonin Inhibits Osteoclastogenesis and Bone Loss in Ovariectomized Mice by Regulating PRMT1-Mediated Signaling. Choi JH; Jang AR; Park MJ; Kim DI; Park JH Endocrinology; 2021 Jun; 162(6):. PubMed ID: 33713122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]